XML 31 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
ASSETS    
Cash and cash equivalents $ 46,942,000 $ 46,686,000
Investment securities available for sale 159,320,000 171,507,000
Loans, less allowance for loan losses of $7,243,000 in 2019 and $6,958,000 in 2018 616,036,000 562,498,000
Other real estate 707,000 1,170,000
Premises and equipment, net 14,629,000 14,287,000
Bank owned life insurance 13,184,000 12,856,000
Accrued interest receivable and other assets 14,373,000 15,394,000
Total assets 865,191,000 824,398,000
Deposits:    
Non-interest bearing 331,619,000 304,039,000
Interest bearing 415,705,000 422,526,000
Total deposits 747,324,000 726,565,000
Repurchase agreements 16,013,000 13,058,000
Accrued interest payable and other liabilities 7,039,000 7,533,000
Junior subordinated deferrable interest debentures 10,310,000 10,310,000
Total liabilities 780,686,000 757,466,000
Commitments and contingencies (Note 11)
Shareholders' equity:    
Serial preferred stock - no par value; 10,000,000 shares authorized; none outstanding
Common stock - no par value; 22,500,000 shares authorized; issued and outstanding – 5,165,760 at December 31, 2019 and 5,137,476 at December 31, 2018 7,312,000 6,944,000
Retained earnings 75,144,000 62,005,000
Accumulated other comprehensive gain (loss), net of taxes 2,049,000 (2,017,000)
Total shareholders' equity 84,505,000 66,932,000
Total liabilities and shareholders' equity $ 865,191,000 $ 824,398,000